ASP Isotopes (ASPI) vs. Its Peers Financial Analysis

ASP Isotopes (NASDAQ:ASPI) is one of 18 public companies in the “Miscellaneous chemical products” industry, but how does it weigh in compared to its rivals? We will compare ASP Isotopes to related companies based on the strength of its risk, profitability, valuation, dividends, analyst recommendations, earnings and institutional ownership.

Insider and Institutional Ownership

1.5% of ASP Isotopes shares are owned by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are owned by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for ASP Isotopes and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	0	0	0	0	N/A
ASP Isotopes Competitors	31	331	310	6	2.43

As a group, “Miscellaneous chemical products” companies have a potential upside of 15.92%. Given ASP Isotopes’ rivals higher probable upside, analysts clearly believe ASP Isotopes has less favorable growth aspects than its rivals.

Profitability

This table compares ASP Isotopes and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	N/A	-116.87%	-90.49%
ASP Isotopes Competitors	-21.17%	0.85%	-7.44%

Earnings and Valuation

This table compares ASP Isotopes and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ASP Isotopes	N/A	-$4.95 million	-2.81
ASP Isotopes Competitors	$1.26 billion	$32.20 million	13.03

ASP Isotopes’ rivals have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

ASP Isotopes rivals beat ASP Isotopes on 8 of the 9 factors compared.

ASP Isotopes Company Profile

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.